Abstract
Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NET) comprise a heterogenous group of cancers defined by their primary site of origin and malignant potential. The liver is the most common site for metastases, and a significant proportion of these patients also have extrahepatic disease (EHD). We performed a population-based study to characterize the impact of liver resection on survival outcomes for metastatic GEP-NET with concurrent EHD.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call